Nagase Diagnostics Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Feb 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 12, 2027The maintenance fee for Measuring method and composition using kinase (US 10,472,665) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 1 fee due Oct 16, 2027The maintenance fee for Method for producing nicotinamide mononucleotide (US 11,959,116) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,080,423 | Reagent containing protease reaction promoter and/or colorant stabilizer In force · From the USPTO record | In force | From the USPTO record | |
| US 10,000,791 | Measurement method for human pancreatic lipase activity In force · From the USPTO record | In force | From the USPTO record | |
| US 10,472,665 | Measuring method and composition using kinase In force · From the USPTO record | In force | From the USPTO record | |
| US 10,900,063 | Measurement of Lp-PLA2 activity In force · From the USPTO record | In force | From the USPTO record | |
| US 11,959,116 | Method for producing nicotinamide mononucleotide In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.